The arbovirus testing market was valued at 1.1 billion dollars worldwide in 2023 and is expected to expand at a compound annual growth rate (CAGR) of 7.1% over the course of the forecast period. The market's demand is being driven by rising healthcare costs and growing awareness of tropical diseases like dengue and chikungunya that are caused by arboviruses but are ignored by the government.

The primary driver of the market's notable expansion is growing public awareness of chronic illnesses. The need for diagnostics, therapies, and vaccinations is being driven by the rise in Zika and West Nile virus incidence. Favorable conditions for vector breeding are being created by urbanization, deforestation, and global warming.

Request For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/arbovirus-testing-market

Growth Drivers

Public health campaigns and investments in mosquito control strategies are becoming more well known. The need for preventative measures and pre-travel vaccines is being driven by travel-related hazards. The market is experiencing high demand due to ongoing efforts to create broad-spectrum antivirals for alphaviruses and flaviviruses.

Urbanization also has a big impact since these vectors thrive in crowded, dirty places without proper sanitation. Furthermore, the expansion of international travel and globalization make it easier for these viruses to traverse national boundaries and infect new areas and populations.

The increasing prevalence of arboviral infections, including dengue, Zika, chikungunya, and West Nile virus, is one of the main causes. Climate change expands the range of habitats for vectors like mosquitoes by producing warmer and more humid conditions that are favorable to their growth.

Segmentation

Infectious Diseases IVD Product

·         Instruments

§  MRSA

§  Streptococcus

§  Clostridium Difficile

§  VRE

§  CRE

§  Respiratory Virus

§  Candida

§  TB and Drug-resistant TB

§  Gastro-intestinal Panel Testing

§  Chlamydia

§  Gonorrhea

§  HPV

§  HIV

§  Hepatitis C

§  Hepatitis B

§  COVID-19

§  Others Infectious Diseases

o   Reagents

§  MRSA

§  Streptococcus

§  Clostridium Difficile

§  VRE

§  CRE

§  Respiratory Virus

§  Candida

§  TB and Drug-resistant TB

§  Gastro-intestinal Panel Testing

§  Chlamydia

§  Gonorrhea

§  HPV

§  HIV

§  Hepatitis C

§  Hepatitis B

§  COVID-19

§  Others Infectious Diseases

o   Software Services

§  MRSA

§  Streptococcus

§  Clostridium Difficile

§  VRE

§  CRE

§  Respiratory Virus

§  Candida

§  TB and Drug-resistant TB

§  Gastro-intestinal Panel Testing

§  Chlamydia

§  Gonorrhea

§  HPV

§  HIV

§  Hepatitis C

§  Hepatitis B

§  COVID-19

§  Others Infectious Diseases

Infectious Diseases IVD Technology

·         Immunoassay

·         Molecular Diagnostics

o   Polymerase Chain Reaction (PCR)

o   In Situ Hybridization

o   Isothermal Nucleic Acid Amplification Technology (INAAT)

o   Chips and Microarrays

o   Sequencing & NGS

o   Transcription Mediated Amplification

·         Others

·         Microbiology

Infectious Diseases IVD Application

·         MRSA

·         Streptococcus

·         Clostridium Difficile

·         VRE

·         CRE

·         Respiratory Virus

·         Candida

·         TB and Drug-resistant TB

·         Gastro-intestinal Panel Testing

·         Chlamydia

·         Gonorrhea

·         HPV

·         HIV

·         Hepatitis C

·         Hepatitis B

·         COVID-19

·         Others Infectious Diseases

Infectious Diseases IVD Test Location

·         Point of Care

·         Central Laboratories

·         Others

By Region

·         Asia-Pacific

·         North America

·         Latin America

·         Middle East and Africa

·         Europe

Key Players

·         Agilent Technologies, Inc.

·         Thermo Fisher Scientific.

·         NovaTec Immundiagnostica GmbH.

·         Euroimmun AG.

·         Abbott Laboratories

·         DiaSorin S.p.A.

·         Hologic Inc.

·         Siemens Healthcare GmbH

·         Inverness Medical Innovations

·         Chembio Diagnostics

·         Ortho Clinical Diagnostics

·         Abbott Laboratories

·         Alere Inc.

·         HoffmannLa Roche Ltd

·         Trinity Biotech Plc

·         Thermo Fisher Scientific Inc.

·         QIAGEN N.V.

·         BioRad Laboratories

·         Danaher Corporation

·         Other Players

For More Information about this Report @ https://www.xresearch.biz/shop/arbovirus-testing-market

About Us: -  

xResearch is a market research and consulting organization that uses unique data, expert analysis, and new technologies to create trusted intelligence on industries. Our research is focused on delivering an informed and impartial view on essential market data of industry, and it is primarily driven by an in-depth study covering the following parameters: Market Sizing and Forecasting, Market Segmentation, Competitive Analysis, Strategic Assessment and Business Modelling.

Contact:                                           
Company Name:  xResearch
Contact Person:  James Lin
Email:  sales@xresearch.biz
Phone: +1 718-619-8140

Websites: https://www.xresearch.biz/